They set a “buy” rating and a $29.00 price objective on the stock. Intevac, Inc. IVAC 17.23% surged 14.4% to $6.81. Commodities. Cloopen Group Holding, a cloud-based communications provider, launched its New York Stock … Adagene has 198 employees across 3 locations and $480 K in annual revenue in FY 2019. ADSs representing ordinary shares, according to an F-1 registration statement. Exchange Rates. Adagene market cap is $974.8 m, and annual revenue was $480 k in FY 2019. Forecasts by Offering (NDT Services, NDT Equipment), Technique (Ultrasonic Testing, Visual Inspection Testing, Magnetic Particle Testing, Liquid Penetrant Testing, Eddy Current Testing, Radiographic Testing, Acoustic Emission Testing, Others), End-users (Oil and Gas, Power Generation, Aerospace and Defence, Automotive, Infrastructure, Manufacturing, Others), Region (North America, … Exchange Rates. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. All other quotes are delayed by at … Adagene Inc (978:DEU) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Adagene is built on a platform designed to expand … 03/29/21. The subscription for their AI stock forecasting services is quite reasonable. NASDAQ:SNDL down nearly 4% on Thursday. Exelixis, Inc. (Nasdaq: EXEL) and Adagene today announced a collaboration and license agreement under which Exelixis will utilize Adagene’s SAFEbody™ technology platform to generate masked versions of monoclonal antibodies from Exelixis’ growing preclinical pipeline for the development of ADCs or other innovative biologics against Exelixis-nominated targets. The Fungal Keratitis Treatment market was valued at approximately USD 702. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. Adagene Inc - ADR stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Veeva Systems Inc (NYSE:VEEV) jumped 10.1% to settle at $291.34 after the company reported better-than-expected Q1 results and issued Q2 FY21 guidance above estimates. This suggests a possible upside of 133.9% from the stock's … Webull Financial LLC is a member of SIPC, which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash). See Adagene Inc. (ADAG) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. $5. The average price target represents a 132.22% upside from the last price of $13.78. Adagene is registered under the ticker NASDAQ:ADAG . NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes. Adagene (ADAG) opened at $20. 40 and peaked at $31. The stock ended Tuesday at $29.99, up nearly 58%. On Tuesday, Adagene collected $140 million after selling 7.35 million shares at $19 each, the top of its $17 to $19 price range. Each ADS represents 1¼ ordinary Adagene shares. ADAG Adagene Inc Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) ... Register now to create your own custom streaming stock watchlist. Adagene’s lead program, ADG106, is a CD-137 agonist currently in phase I in US and China. SAN FRANCISCO and SUZHOU, China, June 16, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that it will be added to the FTSE Global Equity Index Series … This suggests a possible upside of 49.5% from the stock's current price. Adagene Inc is primarely in the business of pharmaceutical preparations. The stock ended Tuesday at $29.99, up nearly 58%. Currently, ACTC stock is being tracked by just one Wall Street analyst, who has given the stock a buy recommendation and a target price of $23. GlobeNewswire. U.S. flags fly half-mast in front of the New York Stock Exchange (NYSE) in New York, U.S., on Friday, Oct. 2, 2020. Analysts covering Adagene Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.347 for the next financial year. Sponsored ADR (ADAG) including 10 year stock price and latest news. Stock Screener. Morgan Stanley started coverage on shares of Adagene in a […] The listing will give Adagene the means to run early-phase clinical trials of antibodies against CD137 and CTLA-4. Chinese firms Cloopen, Adagene kick off US listings. Value stocks can continue to be undervalued by the market for long periods of time. Adagene has raised a total of $155M in funding over 6 rounds. Their latest funding was raised on Feb 11, 2021 from a Post-IPO Equity round. Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The Australia Stock Market Index (AU200) is expected to trade at 7182.84 points by the end of this quarter, according to Trading Economics global macro models and analysts expectations. $17.45 /. Webull Financial LLC is a member of the Financial Industry Regulatory Authority , Securities Investor Protection Corporation , The New York Stock Exchange , NASDAQ and Cboe EDGX Exchange, Inc . Interest Rates. , you can buy Adagene Inc stock in any dollar amount, or any other fund or stock you know on Stash. Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act. The stock … Bearish Bullish. Overview. Market Indexes. See insights on Adagene including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Adagene Inc. (NASDAQ: ADAG) stock … Stocks under 20 dollars, stocks for 20 USD. Shares in Adagene Inc are currently priced at $12.7. Intevac, Inc. IVAC 17.23% surged 14.4% to $6.81. On average, analysts forecast that ADAG's EPS will be $-1.52 for 2021, with the lowest EPS forecast at $-2.10, and the highest EPS forecast at $-0.94. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Adagene Inc. Sundial has all but lost the interest of meme stock … Adagene Inc. (ADAG) stock forecast and price target. Economy. The income statement summarizes the revenues, expenses and profit generated by a business over an annual or quarterly period. Looking forward, we … Latest Adagene Inc (978:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. 3 equities research analysts have issued twelve-month price objectives for Adagene's stock. Cloopen Group Holding, a cloud-based communication provider, is planning to raise at least $100m from a … The price has fallen in 9 of the last 10 days and is down by -21.59% for this period. Close price at the end of the last trading day (Thursday, 27th May 2021) of the ADAG stock was $12.70. ADAG. ) Stock Screener. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Adagene Inc.. Company Details. This is 0.31% less than the trading day before Wednesday, 26th May 2021. Find real-time AMGN - Amgen Inc stock quotes, company profile, news and forecasts from CNN Business. Adagene (ADAG) opened at $20. During the day the stock fluctuated 6.97% from a day low at $11.73 to a day high of $12.55. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more. There are 2 AI stock prediction software companies you should be trying out. Announces Pricing of Initial Public Offering. (NASDAQ: ADAG) Adagene's current Earnings Per Share (EPS) is -$3.34. 40 and peaked at $31. SAN FRANCISCO, Calif. and SUZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene") (NASDAQ:ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that Adagene's Co-founder, Chief Executive Officer and Chairman, Peter Luo, Ph.D., will … Sponsored ADR ADAG investment & stock information. Their stock opened with $19.00 in its Feb 9, 2021 IPO. If you had invested in Adagene stock at $29.99, your return over the last 0 years would have been -55.99%. Adagene stock was originally listed at a price of $29.99 in Feb 9, 2021. Adagene Inc. (ADAG) Suzhou, China-based Adagene Inc made its debut on the Nasdaq Global Select Market on February 9, under the ticker symbol "ADAG." Adagene (NASDAQ:ADAG) Price Target and Consensus Rating 3 Wall Street analysts have issued ratings and price targets for Adagene in the last 12 months. Adagene combines computational biology and artificial intelligence to design novel … The company belongs in the Biotechnology industry, Healthcare sector and employs 198 … Selected key stats of Adagene Inc. View today's stock price, news and analysis for Adagene Inc. ADR (ADAG). Market Indexes. Adagene is a good option in this regard, with the company smashing market predictions on earnings per share in the past fiscal year by $0.20. AI Stock Market Prediction Software, Tools and Apps. The motion of proteins and their dynamic interactions trigger a cascade of complex biological and pharmacological effects. Adagene Inc. (ADAG), a platform-driven, ... Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. View Adagene Inc. Adagene Inc. is followed by the analysts listed above. Ten years of annual and quarterly financial ratios and margins for analysis of Adagene (ADAG). Adagene Inc. (NASDAQ: ADAG) stock closed at 13.53 per share at the end of the most recent trading day (a -1.46 % change compared to the prior day closing price) with a volume of 4.90K shares and market capitalization of 591.41M.Is a component of indices and it is traded on NASDAQ exchange. Adagene, a Phase 1 biotech developing antibody cancer immunotherapies in China, raised $140 million by offering 7.4 million ADSs at $19, the high end of the range of $17 to $19. During the day the stock fluctuated 5.10% from a day low at $12.67 to a day high of $13.32. Showing 1,201-1,300 of 14,842 items. View Adagene stock / share price, financial statements, key ratios and more at Craft. Adagene Inc - ADR Stock Price Forecast for 2021: May 2021: Open: 9.284: Close: 3.372: Min: 3.372: Max: 9.284: Change: -175.3 % Adagene Inc - ADR Stock Price Forecast for 2021: June 2021: Open: 3.248: Close: 0.0123: Min: 0.0123: Max: 3.248: Change: -26240.96 % Adagene Inc - ADR Stock Price Forecast for 2021: July 2021: Open: 0.00925: Close: 0.000022: Min: 0.0000220 How much is Adagene's stock price per share? Top Dividend Stocks. Energy. Top Dividend Stocks. A number of other equities analysts have also recently weighed in on ADAG. Precious Metals. 43,852,894 ordinary shares, par value US$0.0001 per share, as of December 31, 2020. It is also a measure of investors' predictions about future volatility of the underlying stock. Their forecasts range from $29.00 to $34.00. Adagene, Inc. (ADAG) Stock Price: $13.85 USD -0.01 (-0.07%) Updated Jun 17, 2021 4:00 PM EDT - Market closed. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. Jefferies Financial Group started coverage on shares of Adagene in a research report on Monday. Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Their forecasts range from $8.00 to $8.00. LOS ANGELES, March 17, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. This price target is based on 3 analysts offering 12 month price targets for Adagene in the last 3 months. Company profile for Adagene Inc. ADR including key executives, insider trading, ownership, revenue and average growth rates. Adagene has created a platform composed of unique, multi-purpose, antibody technologies and a growing pipeline of leading assets with novel MOAs. Adagene Financial Ratios for … The resulting number helps traders determine whether the premium of an option is "fair" or not. Monday, March 29, 2021. Adagene announced the interim dose-escalation data up to 0.3 mg/kg in its ongoing Phase 1 clinical trial in Australia evaluating the safety and tolerability of ADG116 in patients with advanced/metastatic solid tumors. MOGU Inc. (NYSE:MOGU) shares rose 9.2% to close at $1.67 after reporting Q4 results. (NASDAQ: ADAG) Adagene stock price per share is $13.20 today (as of May 21, 2021). On average, they anticipate Adagene's stock price to reach $32.00 in the next year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Adagene stock. View analyst ratings for Adagene or view top-rated stocks. What stocks does MarketBeat like better than Adagene? I Know First and FinBrain are two we look at here. Biotech Firm Adagene Plans $200 Million U.S. IPO. Registration of securities of foreign private issuers … According to present data Aim Exploration's AEXE shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Side-by-Side View. This means that if you invested $100 now, your current investment may be worth 4.513$ on 2022 June 18, Saturday. Get the latest Adagene Inc. Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Future price of the stock is predicted at 0.085738$ ( -95.487% ) after a year according to our prediction system. 94 million in 2026, with a CAGR of 5. The brokerage issued a buy rating and a $33.00 target price on the stock. Chinese cancer biotech Adagene has filed to raise up to $125 million in a Nasdaq IPO. (ADAG) raised $133 million in an initial public offering on Tuesday, February 9th 2021. The company issued 7,400,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs (Asia), Morgan Stanley and Jefferies served as the underwriters for the IPO and China Renaissance was co-manager. A Side-by-Side View lists Calls on the left and Puts on the right. The Goldman Sachs Group assumed coverage on shares of Adagene in a research report on Friday, March 5th. The high price target for ADAG is $34.00 and the low price target for ADAG is $29.00. For financial reporting, their fiscal year ends on December 31st. Jefferies Financial Group started coverage on shares of Adagene (NASDAQ:ADAG) in a report released on Monday, Benzinga reports. Analyst Coverage. ADAGENE INC. Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Investors have until the deadlines listed below to file a lead plaintiff motion. As of 2021 April 07, Wednesday current price of ADAG stock is 17.310$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). SEC Filings. SAN FRANCISCO, Calif. and SUZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced that Adagene’s Co-founder, Chief … This means that this stock is not suited as a new addition to your portfolio as trading in bear markets, especially for less experienced traders, is always harder. Economy. $25. $50. Adagene (Adagene: ADAG) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. Commodities. SAN FRANCISCO and SUZHOU, China, March 16, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced the first patients have been dosed in its global Phase 1 … Their average twelve-month price target is $32.00, predicting that the stock has a possible upside of 135.47%. Chinese firms Adagene, Cloopen eye US listings. Adagene Reports Full Year 2020 Financial Results and Provides Corporate Updates GlobeNewswire. Find the latest Adagene Inc. (ADAG) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. Stock Research. Adagene is backed by top tier global venture funds including F-Prime Capital Partners, Eight Roads Ventures, Wuxi Pharmatech Healthcare Fund I L.P., GP Healthcare Capital, New World TMT Ltd and Sequoia China. 3 Wall Street analysts have issued twelve-month target prices for Agenus' stock. -NEObody™ product candidate ADG116 has been well tolerated in ongoing Phase 1 clinical trial- -Promising pharmacodynamic biomarker signals demonstrate clinical proof of mechanism--Poised for global expansion- SAN FRANCISCO and SUZHOU, China, March 29, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical … Adagene is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Life is motion . Adagene… The Adagene Inc. stock price fell by -6.72% on the last day (Monday, 10th May 2021) from $12.65 to $11.80. This page contains information on users’ sentiments for the Adagene Inc stock, which are displayed both on charts of different periods of time and on a detailed table. Interest Rates. The average price target is $32.00, with a high forecast of $34.00 and a low forecast of $29.00. Last: The last traded price for … Proterra’s stock forecast. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Aim Exploration share forecasts, stock quote and buy / sell signals below. Stock Research. Adagene Inc (. The following represents disclosure information provided by authors of this abstract. Adagene Inc. American Depositary Shares (ADAG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ADAGENE INC. : Forcasts, revenue, earnings, analysts expectations, ratios for ADAGENE INC. Stock | ADAG | US0053291078 Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … BlackBerry Limited (NYSE:BB) gained 14% to $11.35 amid renewed retail investor interest in the stock. Adagene, founded in 2011, is a clinical-stage biopharmaceutical company developing antibody-based cancer immunotherapies, using its AI-Powered DPL platform. Adagene. SNDL Stock Forecast: Sundial Growers Inc escapes penny-stock territory, set to extend gains. Users ranking according to the performance of their sentiments for the Adagene Inc stock. Adagene Inc. (NASDAQ:ADAG) surged 13.8% to $14.45. At that level they are trading at 0.151% discount to the analyst consensus target price of 0.00. Adagene Presents Clinical Data from NEObody(TM) Program, ADG106, Anti-CD137 Agonist, in an Abstract at ASCO 2021 Annual Meeting GlobeNewswire. Precious Metals. 31 million in 2020 and is expected to witness a revenue of USD 962. Ten years of annual and quarterly income statements for Adagene (ADAG). Adagene is funded by 11 investors. -0.55 (-3.06%) Adagene announced the…. and has now fallen 10 days in a row. 07:45 AM ET ADAG. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare FuelCell Energy against related stocks people … Australia Stock Market Index (AU200) - Forecast. Please note that any opinions, estimates or forecasts regarding Adagene Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Adagene Inc. or its management. BlackBerry Limited BB 5.82% gained 14% to $11.35 amid renewed retail investor interest in the stock. Sponsored ADR ADAG detailed stock quotes, stock … They set a “buy” rating and a $33.00 price target on the stock. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. BlackBerry Limited (NYSE:BB) gained 14% to $11.35 amid renewed retail investor interest in the stock. Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene Inc. (NASDAQ:ADAG) surged 13.8% to $14.45. On average, they expect Agenus' share price to reach $8.00 in the next twelve months. Comment Guidelines . Will you be getting your investment guidance from an artificial intelligence stock price prediciton solution in 2020? Growth stocks can be more volatile than other types of stocks. Wednesday, March 31, 2021. Date Range. Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share. Energy. Adagene Inc. (NASDAQ:ADAG) gained 11.7% to settle at $14.18. Learn about ADAG (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. View detailed ADAG description & address. Stock analysis for Adagene Inc (ADAG:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.